Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
- PMID:11544530
- DOI: 10.1038/35092584
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Abstract
CDKN2A (INK4a/ARF) is frequently disrupted in various types of human cancer, and germline mutations of this locus can confer susceptibility to melanoma and other tumours. However, because CDKN2A encodes two distinct cell cycle inhibitory proteins, p16INK4a and p14ARF (p19Arf in mice), the mechanism of tumour suppression by CDKN2A has remained controversial. Genetic disruption of Cdkn2a(p19Arf) (hereafter Arf) alone predisposes mice to tumorigenesis, demonstrating that Arf is a tumour-suppressor gene in mice. We mutated mice specifically in Cdkn2a(p16Ink4a) (hereafter Ink4a). Here we demonstrate that these mice, designated Ink4a*/*, do not show a significant predisposition to spontaneous tumour formation within 17 months. Embryo fibroblasts derived from them proliferate normally, are mortal, and are not transformed by oncogenic HRAS. The very mild phenotype of the Ink4a*/* mice implies that the very strong phenotypes of the original Ink4a/ArfDelta2,3 mice were primarily or solely due to loss of Arf. However, Ink4a*/Delta2,3 mice that are deficient for Ink4a and heterozygous for Arf spontaneously develop a wide spectrum of tumours, including melanoma. Treatment of these mice with the carcinogen 7,12-dimethylbenzanthracene (DMBA) results in an increased incidence of melanoma, with frequent metastases. Our results show that, in the mouse, Ink4a is a tumour-suppressor gene that, when lost, can recapitulate the tumour predisposition seen in humans.
Similar articles
- Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis.Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW, DePinho RA.Sharpless NE, et al.Nature. 2001 Sep 6;413(6851):86-91. doi: 10.1038/35092592.Nature. 2001.PMID:11544531
- p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.Krimpenfort P, Ijpenberg A, Song JY, van der Valk M, Nawijn M, Zevenhoven J, Berns A.Krimpenfort P, et al.Nature. 2007 Aug 23;448(7156):943-6. doi: 10.1038/nature06084.Nature. 2007.PMID:17713536
- Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo.Sharpless NE, Kannan K, Xu J, Bosenberg MW, Chin L.Sharpless NE, et al.Oncogene. 2003 Aug 7;22(32):5055-9. doi: 10.1038/sj.onc.1206809.Oncogene. 2003.PMID:12902988
- [The INK4a-ARF locus: role in the genetic predisposition to familial melanoma and in skin carcinogenesis].Soufir N, Basset-Seguin N.Soufir N, et al.Bull Cancer. 2001 Nov;88(11):1061-7.Bull Cancer. 2001.PMID:11741799Review.French.
- The INK4a/ARF locus and melanoma.Sharpless E, Chin L.Sharpless E, et al.Oncogene. 2003 May 19;22(20):3092-8. doi: 10.1038/sj.onc.1206461.Oncogene. 2003.PMID:12789286Review.
Cited by
- A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.Rheinwald JG, Hahn WC, Ramsey MR, Wu JY, Guo Z, Tsao H, De Luca M, Catricalà C, O'Toole KM.Rheinwald JG, et al.Mol Cell Biol. 2002 Jul;22(14):5157-72. doi: 10.1128/MCB.22.14.5157-5172.2002.Mol Cell Biol. 2002.PMID:12077343Free PMC article.
- Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of Gadd45a.Bulavin DV, Kovalsky O, Hollander MC, Fornace AJ Jr.Bulavin DV, et al.Mol Cell Biol. 2003 Jun;23(11):3859-71. doi: 10.1128/MCB.23.11.3859-3871.2003.Mol Cell Biol. 2003.PMID:12748288Free PMC article.
- Epstein-Barr virus LMP1 blocks p16INK4a-RB pathway by promoting nuclear export of E2F4/5.Ohtani N, Brennan P, Gaubatz S, Sanij E, Hertzog P, Wolvetang E, Ghysdael J, Rowe M, Hara E.Ohtani N, et al.J Cell Biol. 2003 Jul 21;162(2):173-83. doi: 10.1083/jcb.200302085. Epub 2003 Jul 14.J Cell Biol. 2003.PMID:12860972Free PMC article.
- A senescence rescue screen identifies BCL6 as an inhibitor of anti-proliferative p19(ARF)-p53 signaling.Shvarts A, Brummelkamp TR, Scheeren F, Koh E, Daley GQ, Spits H, Bernards R.Shvarts A, et al.Genes Dev. 2002 Mar 15;16(6):681-6. doi: 10.1101/gad.929302.Genes Dev. 2002.PMID:11914273Free PMC article.
- A pathway for the control of anoikis sensitivity by E-cadherin and epithelial-to-mesenchymal transition.Kumar S, Park SH, Cieply B, Schupp J, Killiam E, Zhang F, Rimm DL, Frisch SM.Kumar S, et al.Mol Cell Biol. 2011 Oct;31(19):4036-51. doi: 10.1128/MCB.01342-10. Epub 2011 Jul 11.Mol Cell Biol. 2011.PMID:21746881Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous